SCHEMBL8778515

SCHEMBL8778515

CC[C](N)Cc1ccccc1

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CES2 O00748 1/20 0.46
CES1 P23141 1/20 0.46
AKR1B1 P15121 1/20 0.46
TP53 P04637 1/20 0.46
NOS2 P35228 3/20 0.43
HIF1A Q16665 1/20 0.42
ALDH1A1 P00352 2/20 0.42
MAPK1 P28482 1/20 0.42
L3MBTL1 Q9Y468 1/20 0.42
KMT2A Q03164 2/20 0.41
LMNA P02545 1/20 0.41
GAA P10253 1/20 0.41
HTT P42858 1/20 0.41
SMN1; SMN2 Q16637 1/20 0.41
PAM P19021 1/20 0.41
TSHR P16473 2/20 0.40
MEN1 O00255 1/20 0.40
HDAC8 Q9BY41 1/20 0.40
HDAC6 Q9UBN7 1/20 0.40
LOXL2 Q9Y4K0 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL28085046 0.79 CES1 (0.55) CES2CES1AKR1B1NOS2HIF1A
SCHEMBL7373328 0.78 CES1 (0.48) CES2CES1AKR1B1NOS2HIF1A
SCHEMBL27374049 0.77 ALDH1A1 (0.52) TP53ALDH1A1MAPK1KMT2ASMN1; SMN2
SCHEMBL9520947 0.76 ALDH1A1 (0.46) CES2CES1AKR1B1NOS2HIF1A
Urea SCHEMBL6171504 0.76 CES1 (0.52) CES2CES1AKR1B1HIF1AALDH1A1
SCHEMBL595614 0.75 CES1 (0.50) CES2CES1AKR1B1TP53ALDH1A1
SCHEMBL3559545 0.75 CES1 (0.50) CES2CES1AKR1B1TP53ALDH1A1
SCHEMBL6318661 0.75 NOS2 (0.52) CES2CES1AKR1B1TP53NOS2
SCHEMBL5184996 0.74 CES1 (0.55) CES2CES1AKR1B1NOS2HIF1A
SCHEMBL8993215 0.74 CES1 (0.55) CES2CES1AKR1B1NOS2HIF1A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0813542-A1 AMINO ACID HYDROXYETHYLAMINO SULFONAMIDE RETROVIRAL PROTEASE INHIBITORS G.D. SEARLE & CO. (US) 1997-12-29 EP disclosed